Sunday, November 20, 2011
Print Current Day:
|
|
SESSION 50 SCHEDULE | |
Sunday
SESSION 50:
NEW DEVELOPMENTS, CONCEPTS, UPDATES AND TECHNIQUES FOR EVALUATING CAROTID PLAQUES (5-MINUTE TALKS)
Moderators:John E. Connolly, MD / Richard M. Green, MD
|
|
x | |
PLENARY SESSIONS (SESSIONS 50 - 54) - LOCATION: GRAND BALLROOM, 3RD FLOOR | |
6:40 AM - 6:45 AM | Strategies For Radiation Dose Reduction In The EVAR Patient Perioperatively And Postoperatively |
Presenter(s):Sailen G. Naidu, MD | |
6:46 AM - 6:51 AM | The First Description Of The Surgeon-Made Fenestrated Graft For EVAR: What Is New With These Devices |
Presenter(s):Krassi Ivancev, MD, PhD / Mark A. Farber, MD | |
6:52 AM - 6:57 AM | Update On New Techniques For Physician-Modified Fenestrated And Branched Stent-Grafts For Urgent Situations |
Presenter(s):Gustavo S. Oderich, MD | |
6:58 AM - 7:03 AM | How Can The Outback Catheter Help In The Performance Of EVAR |
Presenter(s):Mark A. Farber, MD | |
7:04 AM - 7:09 AM | Intrasac Pressure Measurements After EVAR: Can They Vary Within The Sac: What Is Their Value |
Presenter(s):Scott L. Stevens, MD | |
7:10 AM - 7:15 AM | A Simplified Less Invasive Technique For Ilio-Femoral Aneurysm Repair Using Endografts With Minimal Dissection |
Presenter(s):Zoran Rancic, MD, PhD | |
7:16 AM - 7:21 AM | CAS Under Ultrasound Guidance Is A Safer, Better Way |
Presenter(s):Ramon L. Varcoe, MD | |
7:22 AM - 7:27 AM | Mechanisms To Explain The Currently Higher Stroke Rates With CAS Than CEA In Symptomatic Patients: Options And Improvements To Improve CAS Outcomes |
Presenter(s):Kosmas I. Paraskevas, MD / Dimitri P. Mikhailidis, MD / Frank J. Veith, MD | |
7:28 AM - 7:34 AM | Panel Discussion |
TECHNIQUES FOR EVALUATING CAROTID PLAQUES | |
Moderator(s): Nicholas J.W. Cheshire, MD / Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
7:34 AM - 7:39 AM | DEBATE: New Techniques To Assess Carotid Plaques At High Risk For CAS; And If Asymptomatic At High Risk For Causing A Stroke |
Presenter(s):Giorgio M. Biasi, MD | |
7:40 AM - 7:45 AM | DEBATE: Plaque Composition On Ultrasound Examination Is A Poor Predictor Of Cerebral Embolization During CAS |
Presenter(s):Carlos H. Timaran, MD | |
7:46 AM - 7:51 AM | How To Assess High Risk Carotid Plaques With High Embolic Potential By Contrast Enhanced Duplex So They Can Be Treated Safely: How Should That Be Done |
Presenter(s):Laura Capoccia, MD, PhD | |
7:52 AM - 7:57 AM | Advances In PET Studies To Predict Asymptomatic Carotid Plaque Vulnerability: Will It Have Clinical Value |
Presenter(s):Clark J. Zeebregts, MD, PhD | |
7:58 AM - 8:04 AM | How Can We Tell Which Asymptomatic Carotid Plaque Will Cause Strokes And What Should Be Done About It: CAS, CEA, More Statins: Imaging Of Atherosclerosis Gives The Best Assessment Of The Plaque; Of The Patient |
Presenter(s):Henrik Sillesen, MD, DMSc | |
8:04 AM - 8:17 AM | Panel Discussion |
END OF SESSION 50 | |
SESSION 51 SCHEDULE | |
Sunday
SESSION 51:
MORE ABOUT THORACIC AND ABDOMINAL ANEURYSMS (5-MINUTE TALKS)
Moderators:Ramon Berguer, MD, PhD / K. Wayne Johnston, MD, FRCS
|
|
x | |
PLENARY SESSIONS (SESSIONS 50 - 54) - LOCATION: GRAND BALLROOM, 3RD FLOOR | |
8:17 AM - 8:22 AM | Late Results >5 Years Of TEVAR For Thoracic Aortic Aneurysms: Are The Repairs Durable |
Presenter(s):Ronald M. Fairman, MD | |
8:23 AM - 8:28 AM | How Are The New TEVAR Devices Helping In The Treatment Of Aortic Lesions Requiring Placement In Or Near The Arch |
Presenter(s):William D. Jordan, Jr., MD | |
8:29 AM - 8:34 AM | False Lumen Embolization To Reduce Pressure And Induce False Lumen Thrombosis With Aortic Dissections: What Embolic Agent Is Best |
Presenter(s):Manish Mehta, MD, MPH | |
8:35 AM - 8:40 AM | Unusual Inflow Sources And Device Introduction Sites During Aortic Arch Debranching |
Presenter(s):Giovanni P. Deriu, MD | |
8:41 AM - 8:46 AM | Tips And Tricks For Management Of Collapsed Thoracic Endografts |
Presenter(s):Peter L. Faries, MD, FACS | |
8:47 AM - 8:52 AM | Circulating Markers Of AAAs And Their Significance |
Presenter(s):Ronald L. Dalman, MD | |
8:53 AM - 8:58 AM | Panel Discussion |
Moderator(s): Frans L. Moll, MD, PhD / Jean-Pierre Becquemin, MD, FRCS | |
8:58 AM - 9:03 AM | Is EVAR A Good Treatment For Inflammatory AAAs |
Presenter(s):Giovanni Pratesi, MD / Carlo Pratesi, MD | |
9:04 AM - 9:09 AM | New Insights From The PIVOTAL Trial: The Economics Of Treating Small AAAs With EVAR |
Presenter(s):Kenneth Ouriel, MD, MBA, FACS, FACC | |
9:10 AM - 9:15 AM | DEBATE: Preoperative AAA Diameter Influences The Outcome Of EVAR: This Supports Performing EVAR On Smaller <5 cm AAAs In Younger, Fitter Patients |
Presenter(s):James F. McKinsey, MD | |
9:16 AM - 9:21 AM | DEBATE: Nonsense – The Size Threshold For Elective EVAR Should Not Be Lowered |
Presenter(s):Michel S. Makaroun, MD | |
9:22 AM - 9:27 AM | Endovascular Management Of SECONDARY Aortoduodenal Fistulas: Is Laparotomy Eventually Always Required Or Only Sometimes Required |
Presenter(s):Christos D. Liapis, MD | |
9:28 AM - 9:33 AM | DEBATE: Open Repair Is Best For Treatment Of PRIMARY Aortoduodenal Fistulas |
Presenter(s):Gregg S. Landis, MD | |
9:34 AM - 9:39 AM | DEBATE: Some PRIMARY Aortoduodenal Fistulas Should Be Treated By EVAR And In Some Patients It May Be The Definitive Treatment |
Presenter(s):Patrick E. Muck, MD, FACS | |
9:40 AM - 9:55 AM | Panel Discussion/Break Coffee Available in Grand Ballroom Foyer, 3rd Floor |
END OF SESSION 51 | |
SESSION 52 SCHEDULE | |
Sunday
SESSION 52:
NEW DEVELOPMENTS IN DISEASES OF SUPRA-AORTIC TRUNKS, CAROTIDS AND VERTEBRALS (5-MINUTE TALKS)
Moderators:Juan C. Parodi, MD / Glenn Jacobowitz, MD
|
|
x | |
PLENARY SESSIONS (SESSIONS 50 - 54) - LOCATION: GRAND BALLROOM, 3RD FLOOR | |
9:55 AM - 10:00 AM | Endovascular Treatment Strategies For Vertebrobasilar Disease |
Presenter(s):Mark H. Wholey, MD | |
10:01 AM - 10:06 AM | Transradial Approach For Subclavian And Innominate Stenosis: How Can They Allow Safe Stent |
Presenter(s):Craig M. Walker, MD | |
10:07 AM - 10:12 AM | Surgical And Endovascular Treatment Of Vertebral Artery Aneurysms |
Presenter(s):Mark D. Morasch, MD, FACS, RPVI / Ramon Berguer, MD, PhD | |
10:13 AM - 10:18 AM | Management Of Severe Cerebral Ischemia In Takayasu’s Disease: When Are Open Or Endovascular Methods Best |
Presenter(s):Xiaoyun Luo, MD | |
10:19 AM - 10:24 AM | Mini-Incision CEA: How To Do It And Precautions |
Presenter(s):Timothy M. Sullivan, MD | |
10:25 AM - 10:30 AM | How To Avoid Restenosis After CEA |
Presenter(s):Frans L. Moll, MD, PhD | |
10:31 AM - 10:36 AM | Radiation Associated Carotid Stenosis Does Not Mean A Hostile Neck: When Intervention Is Indicated CEA Is The Procedure Of Choice |
Presenter(s):Wesley S. Moore, MD | |
10:37 AM - 10:42 AM | Rapid CEA (RACE) For Symptomatic Carotid Stenosis: What Is It And Is It Working |
Presenter(s):A. Ross Naylor, MD, FRCS | |
10:43 AM - 10:49 AM | Panel Discussion |
Moderator(s): A. Ross Naylor, MD, FRCS / Giancarlo Biamino, MD, PhD | |
10:49 AM - 10:54 AM | Statins Improve The Short-Term And Long-Term Outcomes Of CAS And CEA |
Presenter(s):Piergiorgio Cao, MD, FRCS | |
10:55 AM - 11:00 AM | When Is CEA Contraindicated After Intravenous Thrombolysis For An Acute Stroke Or Hemorrhagic Transformation Of An Embolic Stroke; And When Is It Not |
Presenter(s):Michel A. Bartoli, MD | |
11:01 AM - 11:06 AM | Indiscriminate Stenting Of Asymptomatic Carotid Stenosis: Is It Ill-Advised, Malpractice, Or Criminal |
Presenter(s):J. David Spence, MD | |
11:07 AM - 11:12 AM | The Most Important Steps To Make CAS Work Safely On A Widespread Basis In Symptomatic Patients Needing Treatment |
Presenter(s):Klaus D. Mathias, MD | |
11:13 AM - 11:18 AM | Meta-analysis Of CEA vs. CAS In Over 3400 Symptomatic Patients From RCTs |
Presenter(s):Gustav Fraedrich, MD | |
11:19 AM - 11:24 AM | DEBATE: Closed Cell Stents Decrease Cerebral Embolization |
Presenter(s):Koen Deloose, MD / Marc Bosiers, MD | |
11:25 AM - 11:30 AM | DEBATE: Closed Cell Stents Have No Effect On Cerebral Embolization |
Presenter(s):Carlos H. Timaran, MD | |
11:31 AM - 11:37 AM | Panel Discussion |
END OF SESSION 52 | |
SESSION 53 SCHEDULE | |
Sunday
SESSION 53:
NEW DEVELOPMENTS AND CONTROVERSIES RELATED TO CAS AND CEA (5-MINUTE TALKS)
Moderators:Peter R.F. Bell, MD, FRCS, DSC, KBE / Klaus D. Mathias, MD
|
|
x | |
PLENARY SESSIONS (SESSIONS 50 - 54) - LOCATION: GRAND BALLROOM, 3RD FLOOR | |
11:37 AM - 11:42 AM | Changes In Aortic Arch Anatomy With Aging: Implications For Endovascular Intervention – Especially CAS |
Presenter(s):Brian G. DeRubertis, MD | |
11:43 AM - 11:48 AM | Perioperative Or Intraoperative Carotid Stenting: A Bailout For CEAs Which Go Badly |
Presenter(s):Germano Melissano, MD | |
11:49 AM - 11:54 AM | European Views On CAS vs. CEA |
Presenter(s):Marc R.H. van Sambeek, MD, PhD | |
11:55 AM - 12:00 PM | The Truth About Memory Loss After Invasive Carotid Procedures – CAS And CEA: How Much Does Technique Modification Help |
Presenter(s):Wei Zhou, MD | |
12:01 PM - 12:06 PM | Effect Of Age On Results Of CAS And Cost Analysis Of CEA vs. CAS In CREST |
Presenter(s):W. Charles Sternbergh III, MD | |
12:07 PM - 12:12 PM | Health Related Quality Of Life For CEA And CAS In CREST After 1 Or More Years |
Presenter(s):Fred A. Weaver, MD | |
12:13 PM - 12:18 PM | DEBATE: Why We Don’t Need A Trial Comparing CAS/CEA vs. Best Medical Treatment In Asymptomatic Patients (Web-Based) |
Presenter(s):Alison Halliday, MS, FRCS | |
12:19 PM - 12:24 PM | DEBATE: Why We Do Need A Trial Comparing CAS/CEA vs. Best Medical Treatment: Will We Have One: What Is CREST II And Where Does It Stand |
Presenter(s):Thomas G. Brott, MD | |
12:25 PM - 12:30 PM | Prevalence And Clinical Significance Of Stent Fractures After CAS |
Presenter(s):Mark K. Eskandari, MD | |
12:31 PM - 12:36 PM | When Should CAS Be Aborted |
Presenter(s):Peter A. Schneider, MD | |
12:37 PM - 12:42 PM | Late Results With CAS By A Cervical Approach With Flow Reversal: Technical Aspects |
Presenter(s):David W. Chang, MD | |
12:43 PM - 12:48 PM | Late Results With CAS By A Cervical Approach With Flow Reversal: Indications |
Presenter(s):Enrique Criado, MD, FACS | |
12:49 PM - 12:54 PM | How Does Diabetes Impact On The Outcomes Of CAS And CEA |
Presenter(s):Piergiorgio Cao, MD, FRCS | |
12:55 PM - 1:15 PM | Panel Discussion Lunch Available (In The Grand Ballroom) |
END OF SESSION 53 | |
SESSION 54 SCHEDULE | |
Sunday
SESSION 54:
NEW HORIZONS, CONCEPTS, UPDATES, LATE BREAKING DEVELOPMENTS, HORIZONS (5-MINUTE TALKS)
Moderators:Kenneth Ouriel, MD, MBA, FACS, FACC / James F. McKinsey, MD
|
|
x | |
PLENARY SESSIONS (SESSIONS 50 - 54) - LOCATION: GRAND BALLROOM, 3RD FLOOR | |
1:15 PM - 1:20 PM | Technique For Treating Inferior Vena Cava Involvement With Renal Cell Cancer: Tips And Tricks (Video) |
Presenter(s):R. Clement Darling III, MD | |
1:21 PM - 1:26 PM | DEBATE: The Lifeline Database Yields A Scoring System To Predict Which Patients Have A Likelihood Of Having An AAA: These Patients Should Be Screened: What Is The Scoring System |
Presenter(s):K. Craig Kent, MD | |
1:27 PM - 1:32 PM | DEBATE: This Lifeline System Scoring Should Not Be Used To Pick Patients For Screening: What Should Be Used |
Presenter(s):Frank A. Lederle, MD | |
1:33 PM - 1:38 PM | Latest Information On The Relationship Between Diabetes And Vascular Disease |
Presenter(s):Anton N. Sidawy, MD, MPH | |
1:39 PM - 1:44 PM | Clampless, Bloodless Vascular Surgery With The LeGoo Procedure |
Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA | |
1:45 PM - 1:50 PM | Status Of Trials Comparing CEA And CAS To Best Medical Treatment: We Do Need More Trials |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
1:51 PM - 1:56 PM | A “Smart” Steerable Catheter To Facilitate Endovascular Interventions |
Presenter(s):Robert J. Hinchliffe, MD | |
1:57 PM - 2:02 PM | With Infected EVARs A Semi-Conservative Approach Can Work: What Are The Essential Elements Of This Approach |
Presenter(s):Martin Malina, MD, PhD | |
2:03 PM - 2:10 PM | Panel Discussion |
Moderator(s): Enrico Ascher, MD / Frank J. Veith, MD | |
2:10 PM - 2:15 PM | A Clever New Method To Cannulate The Contralateral Limb Of A Bifurcated Endograft In Less Than 8 Seconds Every Time |
Presenter(s):Willem Wisselink, MD | |
2:16 PM - 2:21 PM | Optimal And Simplified Technique For Subclavian-To-Carotid Transposition |
Presenter(s):Ramon Berguer, MD, PhD / Mark D. Morasch, MD, FACS, RPVI | |
2:22 PM - 2:27 PM | New Concepts In The Treatment Of Arterial Thoracic Outlet Syndrome Without Thromboembolic Complications |
Presenter(s):Enrique Criado, MD, FACS | |
2:28 PM - 2:33 PM | Duplex Guided Treatment Of Acutely Ischemic Limbs |
Presenter(s):Anil P. Hingorani, MD / Enrico Ascher, MD / Natalie A. Marks, MD, RVT | |
2:34 PM - 2:39 PM | ASD Closure Device To Treat A Saccular AAA Close To The SMA |
Presenter(s):Ross Milner, MD | |
2:40 PM - 2:45 PM | What Is The Effect Of Statins In CLI Patients: How Do Statins Affect Mortality, Morbidity And Bypass And Endovascular Treatment Outcomes |
Presenter(s):Darren B. Schneider, MD | |
2:46 PM - 2:55 PM | Panel Discussion |
2:55 PM - 3:05 PM | Raffle Drawing – You Must Be Present To Win |
3:05 PM - 3:05 PM | Symposium Ends. Save The Date For 2012: November 14-18, 2012 at the Hilton New York |
END OF SESSION 54 |